At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LEGN Legend Biotech
Post-Market Trading 05-09 16:24:10 EDT
45.52
-0.20
-0.44%
盘后45.48
-0.04-0.09%
16:13 EDT
High46.17
Low45.28
Vol528.85K
Open45.77
D1 Closing45.72
Amplitude1.95%
Mkt Cap8.28B
Tradable Cap3.61B
Total Shares181.91M
T/O24.21M
T/O Rate0.67%
Tradable Shares79.39M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Should You Buy Legend Biotech (LEGN) Ahead of Earnings?
CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Legend Biotech Corp is a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's differentiated technology, global development and manufacturing strategy and expertise provide it with the ability to generate, test and manufacture next-generation cell therapies targeting indications with high unmet needs.